Vincent S Fan1, Ina Gylys-Colwell2, Emily Locke2, Kaharu Sumino3, Huong Q Nguyen4, Rachel M Thomas2, Sheryl Magzamen5. 1. VA Puget Sound Health Care System, Seattle, WA, USA; University of Washington, Seattle, WA, USA. Electronic address: vincent.fan@va.gov. 2. VA Puget Sound Health Care System, Seattle, WA, USA. 3. Saint Louis VA Medical Center, St. Louis, MO, USA; Washington University School of Medicine, St. Louis, MO, USA. 4. Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA. 5. Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, CO, USA.
Abstract
BACKGROUND: Overuse of short-acting beta-agonists (SABA) is described in asthma, but little is known about overuse of SABA in chronic obstructive pulmonary disease (COPD). METHODS: Prospective 3-month cohort study of patients with moderate-to-severe COPD who were provided a portable electronic inhaler sensor to monitor daily SABA use. Subjects wore a pedometer for 3 seven-day periods and were asked to complete a daily diary of symptoms and inhaler use. Overuse was defined as >8 actuations of their SABA per day while clinically stable. RESULTS: Among 32 participants, 15 overused their SABA inhaler at least once (mean 8.6 ± 5.0 puffs/day), and 6 overused their inhaler more than 50% of monitored days. Compared to those with no overuse, overusers had greater dyspnea (modified Medical Research Council Dyspnea Scale: 2.7 vs. 1.9, p = 0.02), were more likely to use home oxygen (67% vs. 29%, p = 0.04), and were more likely to be on maximal inhaled therapy (long-acting beta-agonist, long-acting antimuscarinic agent, and an inhaled steroid: 40% vs. 6%, p = 0.03), and most had completed pulmonary rehabilitation (67% vs. 0%, p < 0.001). However, 27% of overusers of SABA were not on guideline-concordant COPD therapy. CONCLUSIONS: Overuse of SABA was common and associated with increased disease severity and symptoms, even though overusers were on more COPD-related inhalers and more had completed pulmonary rehabilitation. More research is needed to understand factors associated with inhaler overuse and how to improve correct inhaler use. Published by Elsevier Ltd.
BACKGROUND: Overuse of short-acting beta-agonists (SABA) is described in asthma, but little is known about overuse of SABA in chronic obstructive pulmonary disease (COPD). METHODS: Prospective 3-month cohort study of patients with moderate-to-severe COPD who were provided a portable electronic inhaler sensor to monitor daily SABA use. Subjects wore a pedometer for 3 seven-day periods and were asked to complete a daily diary of symptoms and inhaler use. Overuse was defined as >8 actuations of their SABA per day while clinically stable. RESULTS: Among 32 participants, 15 overused their SABA inhaler at least once (mean 8.6 ± 5.0 puffs/day), and 6 overused their inhaler more than 50% of monitored days. Compared to those with no overuse, overusers had greater dyspnea (modified Medical Research Council Dyspnea Scale: 2.7 vs. 1.9, p = 0.02), were more likely to use home oxygen (67% vs. 29%, p = 0.04), and were more likely to be on maximal inhaled therapy (long-acting beta-agonist, long-acting antimuscarinic agent, and an inhaled steroid: 40% vs. 6%, p = 0.03), and most had completed pulmonary rehabilitation (67% vs. 0%, p < 0.001). However, 27% of overusers of SABA were not on guideline-concordant COPD therapy. CONCLUSIONS: Overuse of SABA was common and associated with increased disease severity and symptoms, even though overusers were on more COPD-related inhalers and more had completed pulmonary rehabilitation. More research is needed to understand factors associated with inhaler overuse and how to improve correct inhaler use. Published by Elsevier Ltd.
Authors: Barbara P Yawn; Gretchen M McCreary; John A Linnell; Cara B Pasquale; Elisha Malanga; Radmila Choate; David A Stempel; Rahul Gondalia; Leanne Kaye; Kathryn A Collison; Benjamin S Wu; Daniel Gratie; Richard H Stanford; Ryan Tomlinson Journal: Chronic Obstr Pulm Dis Date: 2021-10-28
Authors: Amy H Y Chan; Roy A Pleasants; Rajiv Dhand; Stephen L Tilley; Stephen A Schworer; Richard W Costello; Rajan Merchant Journal: Pulm Ther Date: 2021-08-11
Authors: Jessica Chen; Leanne Kaye; Michael Tuffli; Meredith A Barrett; Shelanda Jones-Ford; Tina Shenouda; Rahul Gondalia; Kelly Henderson; Veronica Combs; David Van Sickle; David A Stempel Journal: JMIR Form Res Date: 2019-10-23
Authors: Heinrich Worth; Carl-Peter Criée; Claus F Vogelmeier; Peter Kardos; Eva-Maria Becker; Karel Kostev; Ingo Mokros; Andrea Schneider Journal: Respir Res Date: 2021-04-16
Authors: Chad Moretz; Ashley L Cole; George Mu; Benjamin Wu; Amy Guisinger; Yunhao Liu; Beth Hahn; Lee Baylis Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-09-16
Authors: Daniele Pernigotti; Carol Stonham; Sara Panigone; Federica Sandri; Rossella Ferri; Yasemin Unal; Nicolas Roche Journal: BMJ Open Respir Res Date: 2021-12